Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
One stock well above its 200-day moving average has more room to run, traders agree
11:00am, Monday, 29'th Jun 2020
Shares of Chipotle Mexican Grill have made strides this year, but traders say the stock is set to keep climbing, even in the event of a pullback.
Verus Capital Partners LLC Sells 162 Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
07:42am, Sunday, 28'th Jun 2020
Verus Capital Partners LLC cut its stake in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 67.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi
How Regeneron’s CEO Raced Into Clinical Trials With a Drug Developed for Covid-19
01:30am, Saturday, 27'th Jun 2020
The co-founder and CEO of Regeneron raced into clinical trials with a drug developed for Covid-19.
Meet Barron’s 25 Top CEOs, Who Took on Extraordinary Challenges During 2020
01:13am, Saturday, 27'th Jun 2020
These 25 bosses have navigated extraordinary challenges to keep their companies thriving.
FDA Rejects AbbVie's Macular Degeneration Drug Abicipar Pegol | The Motley Fool
06:11pm, Friday, 26'th Jun 2020
The drug, which AbbVie gained in its acquisition of Allergan, was supposed to be a growth driver for the company.
Xconomy: Eye Inflammation Dooms AbbVie Wet AMD Drug to an FDA Rejection
05:43pm, Friday, 26'th Jun 2020
The FDA has rejected an investigational AbbVie drug for the “wet” form of age-related macular degeneration, dealing a setback to the company’s bid to
Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug
02:24pm, Friday, 26'th Jun 2020
The U.S. district attorney for Massachusetts filed suit against the drugmaker this week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat
Regeneron Used a Charity to Pay Kickbacks, Justice Department Alleges
01:41pm, Friday, 26'th Jun 2020
Regeneron hiked the price of its drug Eylea and spurred its sales by using a charitable foundation to cover Medicare patients’ out-of-pocket costs for the pricey drug, according to a civil suit.
Xconomy: Bio Roundup: Gilead's Pionyr Grab, Relay to IPO, Unicorn Sana & More
12:01pm, Friday, 26'th Jun 2020
Uncertainty related to the continued spread of the pandemic continued to consume most of the oxygen in the room this week, but life sciences news outside
The Incredible Gene-Therapy Breakthroughs to Cure Blindness
08:34am, Friday, 26'th Jun 2020
Some involved the gene-editing technique known as CRISPR. One involves putting a specially engineered gold particle into the retina.
Nuveen Asset Management LLC Purchases 73,787 Shares of Editas Medicine Inc (NASDAQ:EDIT)
06:06am, Friday, 26'th Jun 2020
Nuveen Asset Management LLC raised its stake in shares of Editas Medicine Inc (NASDAQ:EDIT) by 28.9% during the 1st quarter, Holdings Channel reports. The fund owned 328,752 shares of the company’s
Adverum Biotechnologies Announces Appointment of Heikki Jouttijärvi as Vice President of Manufacturing
08:01pm, Thursday, 25'th Jun 2020
Adverum Biotechnologies, Inc. (ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Heikki Jouttijärvi joined the company as vi
How gene therapy and CRISPR are helping to cure blindness
06:11pm, Thursday, 25'th Jun 2020
The eye is an ideal organ for testing new therapeutic approaches, including CRISPR.
Regeneron Used Charity In Kickback Scheme To Pay Medicare Patients, Prosecutors Allege
01:27pm, Thursday, 25'th Jun 2020
Pharmaceutical companies are prohibited from offering remuneration to encourage Medicare to purchase their drugs. The case is one of several investigations into drugmakers’ ties to patient as…
5 of the Best Pharmaceutical Stocks to Buy Right Now
01:05pm, Thursday, 25'th Jun 2020
A handful of pharmaceutical stocks have been on fire these days, but I'm writing for a "buy" prescription for five of the best names now.
